Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Premique Low Dose 0.3mg/1.5mg modified-release tablets
0604011Q0BCAEAH
|
Premique | Oestrogens conjugated with progestogen | Endocrine System | 8,507 |
|
Conj oestrogens 300microg/Medroxyprogesterone 1.5mg MR tab
0604011Q0AAAHAH
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | 391 |
|
Conj oestrogens 1.25mg tab and Norgestrel 150microg tab
0604011Q0AAADAD
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Conj oestrogens 625microg tab and Norgestrel 150microg tab
0604011Q0AAACAC
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Conjugated oestrogens 625microg/Medroxyprogesterone 5mg tab
0604011Q0AAAEAE
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Generic Premique Cycle tablets
0604011Q0AAAGAG
|
Conjugated oestrogens / progestogen | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Premique 0.625mg/5mg tablets
0604011Q0BCADAE
|
Premique | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Premique Cycle 0.625mg/10mg tablets
0604011Q0BCACAG
|
Premique | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Prempak-C 0.625mg/0.15mg tablets
0604011Q0BBACAC
|
Prempak-C | Oestrogens conjugated with progestogen | Endocrine System | No data available |
|
Prempak-C 1.25mg/0.15mg tablets
0604011Q0BBADAD
|
Prempak-C | Oestrogens conjugated with progestogen | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.